Government Funded research

EB152 – Constituency statement for Knowledge Ecology International, Health Action International, Public Services International, Oxfam, and World Council of Churches – Strengthening the global architecture for health emergency preparedness, response and resilience

Posted on by Thiru

On Tuesday, 31 January 2023, Arianna Schouten delivered this constituency statement on behalf of Knowledge Ecology International, Health Action International, Oxfam, Public Services International, and the World Council of Churches on the following topic: “12.1 – Strengthening WHO preparedness for… Continue Reading →

31 January 2023 – Save the Date – Recommendations for the WHO Pandemic Treaty Negotiations

Posted on by Thiru

Recommendations for the WHO Pandemic Treaty Negotiations DATE: Tuesday, 31 January 2023 TIME: 17:30 to 19:00 CET LOCATION: Salle II/III, World Council of Churches, Route de Ferney 150 Refreshments will be served from 17:00 BACKGROUND: The WHO Intergovernmental Negotiating Body… Continue Reading →

25 Members of Congress Ask HHS Secretary to Act on Xtandi Request

Posted on by Claire Cassedy

On January 10, 2023, twenty-five Members of Congress sent a letter to HHS Secretary Xavier Becerra urging him to act on the Xtandi request, and to use the Bayh-Dole Act to lower the price of Xtandi (enzalutamide) for US patients.… Continue Reading →

Member States of the WHO African Region propose ambitious amendments to the International Health Regulations on intellectual property, licensing, transfer of technology, and know-how

Posted on by Thiru

While much attention has been focused on negotiations at the World Health Organization (WHO) on a pandemic treaty, there has been less scrutiny on WHO deliberations on proposed amendments to the International Health Regulations (2005). The reasons are two-fold: 1)… Continue Reading →

WHO pandemic treaty negotiations: Walkthrough of conceptual zero draft for the consideration of the Intergovernmental Negotiating Body at its third meeting

Posted on by Thiru

On 16 November 2022, the Bureau of the Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response (INB) released the conceptual zero draft in all six official languages… Continue Reading →

NIH responds to Sachs/Love letter on the Xtandi Bayh-Dole safeguards petition, to say, still reviewing

Posted on by James Love

NIH has sent a letter, dated Dec 1, to Robert Sachs and Clare Love, regarding the longstanding petition to HHS to use the federal government’s rights in the patented inventions for enzalutamide, marketed by Astellas in the USA at prices 3 to… Continue Reading →

Letter from 19 groups asking HHS to take action on the ​request that HHS use the federal government rights in patents on the prostate drug enzalutamide, marketed by Astellas under the brand name Xtandi.

Posted on by James Love

Attached is a letter from 19 groups asking HHS Secretary Xavier Becerra to take action on the ​request that HHS use the federal government rights in patents on the prostate drug enzalutamide, marketed by Astellas under the brand name Xtandi.… Continue Reading →

Letter to Secretary of HHS Xavier Becerra regarding Xtandi march-in case from Robert Sachs and Clare Love

Posted on by James Love

SecBecerra-18Nov2022-Sachs-Love-Xtandi November 18, 2022 Xavier Becerra Secretary Department of Health & Human Services Washington, DC Via Email: xavier.becerra@hhs.gov Dear Secretary Becerra: Today marks the one-year anniversary since the undersigned prostate cancer patients petitioned the Department of Health & Human Services… Continue Reading →

166 contracts disclosed in SEC filings include authorizations to use U.S. patents without consent from patent holders

Posted on by KEI Staff

On 12 October 2022, Knowledge Ecology International (KEI) published a briefing note on the U.S. federal government FAR 52.227-1 authorizations (for non voluntary use of patents) disclosed in 166 SEC exhibits. KEI Briefing Note 2022:2, Federal government FAR 52.227-1 authorizations… Continue Reading →